LIST OF EXHIBITS
EXHIBIT 1 SEGMENTATION OF GLOBAL BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET
EXHIBIT 2 MARKET SIZE CALCULATION APPROACH 2021
EXHIBIT 3 BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET 2021-2027 (& BILLION)
EXHIBIT 4 PIPELINE OF BIOSIMILARS BY PHASES OF DEVELOPMENT (2013 AND 2020)
EXHIBIT 5 GLOBAL BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET SEGMENTATIONS
EXHIBIT 6 IMPACT OF M&AS AMONG BIOPHARMACEUTICAL MANUFACTURERS
EXHIBIT 7 IMPACT OF ROBUST BIOPHARMACEUTICALS PIPELINE
EXHIBIT 8 PIPELINE OF BIOSIMILARS BY PHASES OF DEVELOPMENT (2013 AND 2020)
EXHIBIT 9 INDUSTRIAL SPONSORED TRIALS OF C> IN THE PIPELINE
EXHIBIT 10 VACCINES IN PIPELINE FOR VARIOUS INFECTIOUS DISEASES
EXHIBIT 11 IMPACT OF INCREASED MANUFACTURING OF GENE THERAPIES BY CMOS
EXHIBIT 12 MAJOR ADVANTAGES OF ENGAGING WITH CMOS
EXHIBIT 13 FACTORS CONSIDERED IN PARTNERSHIP WITH CONTRACT MANUFACTURERS
EXHIBIT 14 IMPACT OF PRODUCT LAUNCHES & REGULATORY APPROVALS
EXHIBIT 15 IMPACT OF INCREASE BIOLOGICS MANUFACTURING OUTSOURCING BY PHARMA AND BIOTECH COMPANIES
EXHIBIT 16 CATEGORIES OF BIOMANUFACTURERS OUTSOURCING ACTIVITIES 2017 (% SHARE)
EXHIBIT 17 IMPACT OF RAPID EXPANSION OF BIOPHARMACEUTICALS MANUFACTURING SERVICE OFFERINGS
EXHIBIT 18 IMPACT OF SURGE IN MANUFACTURING CAPACITY EXPANSION POST COVID BY CDMOS AND CMOS
EXHIBIT 19 IMPACT OF HIGH DEMAND FOR BIOLOGICAL PRODUCTS
EXHIBIT 20 NEW DRUG THERAPIES APPROVED BY US-FDA
EXHIBIT 21 IMPACT OF HIGH COST OF TREATMENT TO RESTRAIN BIOLOGICS CONTRACT MANUFACTURING MARKET
EXHIBIT 22 IMPACT OF LACK OF STORAGE INFRASTRUCTURE & LIMITATIONS ASSOCIATED WITH SUPPLY CHAIN
EXHIBIT 23 MAJOR BARRIERS TO EFFECTIVE VACCINE HANDLING AND STORAGE (% SHARE)
EXHIBIT 24 IMPACT OF HIGH COST OF ESTABLISHING BIOLOGICS MANUFACTURING FACILITY
EXHIBIT 25 TOP 10 GLOBAL MANUFACTURING HUBS
EXHIBIT 26 MAJOR GROWTH FACTORS OF BIOPHARMACEUTICAL MARKET
EXHIBIT 27 GLOBAL BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET 2021–2027 ($ BILLION)
EXHIBIT 28 GLOBAL BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY GEOGRAPHY
EXHIBIT 29 GLOBAL BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY PRODUCT
EXHIBIT 30 GLOBAL BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY BIOLOGICS
EXHIBIT 31 GLOBAL BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY EXPRESSION SYSTEM
EXHIBIT 32 GLOBAL BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY SCALE OF OPERATION
EXHIBIT 33 GLOBAL BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY COMPANY SIZE
EXHIBIT 34 FIVE FORCES ANALYSIS 2021
EXHIBIT 35 INCREMENTAL GROWTH BY PRODUCT 2021 & 2027
EXHIBIT 36 GLOBAL BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY CONTRACT TYPE
EXHIBIT 37 GLOBAL BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY PRODUCT: INCREMENTAL GROWTH
EXHIBIT 38 GLOBAL BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY PRODUCT: ABSOLUTE GROWTH
EXHIBIT 39 GLOBAL BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY FINISHED DOSAGE FORM: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 40 GLOBAL BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY FDF 2021–2027 ($ BILLION)
EXHIBIT 41 GLOBAL BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY ACTIVE PHARMACEUTICAL INGREDIENTS (APIS): INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 42 GLOBAL BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY APIS 2021–2027 ($ BILLION)
EXHIBIT 43 INCREMENTAL GROWTH BY BIOLOGICS 2021 & 2027
EXHIBIT 44 GLOBAL BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY BIOLOGICS
EXHIBIT 45 GLOBAL BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY BIOLOGICS: INCREMENTAL GROWTH
EXHIBIT 46 DIFFERENT TYPES OF COVID-19 VACCINES UNDER RESEARCH BY 2020
EXHIBIT 47 GLOBAL BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY BIOLOGICS: ABSOLUTE GROWTH
EXHIBIT 48 GLOBAL BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY MONOCLONAL ANTIBODIES (MABS): INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 49 GLOBAL BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY MONOCLONAL ANTIBODIES (MABS) 2021–2027 ($ BILLION)
EXHIBIT 50 GLOBAL BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY VACCINES: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 51 GLOBAL BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY VACCINE 2021–2027 ($ BILLION)
EXHIBIT 52 CELL AND GENE THERAPY PRODUCT APPROVALS & LAUNCH DETAILS
EXHIBIT 53 GLOBAL BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY VACCINE: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 54 GLOBAL BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY OTHERS 2021–2027 ($ BILLION)
EXHIBIT 55 INCREMENTAL GROWTH BY EXPRESSION SYSTEM 2021 & 2027
EXHIBIT 56 GLOBAL BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY EXPRESSION SYSTEM
EXHIBIT 57 DIFFERENT EXPRESSION SYSTEMS OFFERED BY CDMOS
EXHIBIT 58 GLOBAL BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY EXPRESSION SYSTEM: INCREMENTAL GROWTH
EXHIBIT 59 GLOBAL BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY EXPRESSION SYSTEM: ABSOLUTE GROWTH
EXHIBIT 60 GLOBAL BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY MAMMALIAN: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 61 GLOBAL BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY MAMMALIAN 2021–2027 ($ BILLION)
EXHIBIT 62 GLOBAL BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY NON-MAMMALIAN: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 63 GLOBAL BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY NON-MAMMALIAN 2021–2027 ($ BILLION)
EXHIBIT 64 INCREMENTAL GROWTH BY SCALE OF OPERATIONS 2021 & 2027
EXHIBIT 65 GLOBAL BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY SCALE OF OPERATIONS
EXHIBIT 66 GLOBAL BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY SCALE OF OPERATION: INCREMENTAL GROWTH
EXHIBIT 67 GLOBAL BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY SCALE OF OPERATION: ABSOLUTE GROWTH
EXHIBIT 68 FDA-APPROVED COMMERCIALIZED GENE THERAPY PRODUCTS IN US
EXHIBIT 69 GLOBAL BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY COMMERCIAL SEGMENT: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 70 TOP SELLING BIOPHARMACEUTICALS DRUGS WORLDWIDE IN 2019 ($ BILLION)
EXHIBIT 71 GLOBAL BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY COMMERCIAL 2021–2027 ($ BILLION)
EXHIBIT 72 GLOBAL BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY RESEARCH (CLINICAL & PRECLINICAL) SEGMENT: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 73 GLOBAL BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY RESEARCH (CLINICAL & PRECLINICAL) 2021–2027 ($ BILLION)
EXHIBIT 74 INCREMENTAL GROWTH BY COMPANY SIZE 2021 & 2027
EXHIBIT 75 GLOBAL BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY COMPANY SIZE
EXHIBIT 76 GLOBAL BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY COMPANY SIZE: INCREMENTAL GROWTH
EXHIBIT 77 GLOBAL BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY COMPANY SIZE: INCREMENTAL GROWTH
EXHIBIT 78 GLOBAL BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY LARGE COMPANIES SEGMENT: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 79 GLOBAL BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY LARGE COMPANIES 2021–2027 ($ BILLION)
EXHIBIT 80 GLOBAL BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY LARGE COMPANIES SEGMENT: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 81 GLOBAL BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY SMALL & MID-SIZED COMPANIES 2021–2027 ($ BILLION)
EXHIBIT 82 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 83 GLOBAL CONTRACT MANUFACTURING MARKET BY GEOGRAPHY
EXHIBIT 84 GLOBAL BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET: KEY COUNTRIES
EXHIBIT 85 COMPARISON OF PHARMA & BIOTECH COMPANIES WILLING TO OUTSOURCE BIOPHARMACEUTICAL MANUFACTURING IN SELECT COUNTRIES 2020 & 2026
EXHIBIT 86 GLOBAL BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY GEOGRAPHY: INCREMENTAL GROWTH
EXHIBIT 87 GLOBAL BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY GEOGRAPHY: ABSOLUTE GROWTH
EXHIBIT 88 BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET IN NORTH AMERICA: KEY COUNTRIES
EXHIBIT 89 BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET IN NORTH AMERICA: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 90 NUMBER OF REGENERATIVE MEDICINE MANUFACTURERS IN NORTH AMERICA 2017-2021
EXHIBIT 91 BIOPHARMACEUTICAL CONTRACT MANUFACTURING IN NORTH AMERICA 2021–2027 ($ BILLION)
EXHIBIT 92 INCREMENTAL GROWTH BY PRODUCT 2021 & 2027
EXHIBIT 93 INCREMENTAL GROWTH BY BIOLOGICS 2021 & 2027
EXHIBIT 94 INCREMENTAL GROWTH BY EXPRESSION SYSTEM 2021 & 2027
EXHIBIT 95 INCREMENTAL GROWTH BY SCALE OF OPERATION 2021 & 2027
EXHIBIT 96 INCREMENTAL GROWTH BY COMPANY SIZE 2021 & 2027
EXHIBIT 97 INCREMENTAL GROWTH IN NORTH AMERICA 2021 & 2027
EXHIBIT 98 BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET IN US 2021–2027 ($ BILLION)
EXHIBIT 99 BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET IN CANADA 2021–2027 ($ BILLION)
EXHIBIT 100 GLOBAL BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET IN EUROPE: KEY COUNTRIES
EXHIBIT 101 BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET IN EUROPE: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 102 BIOPHARMACEUTICAL CONTRACT MANUFACTURING IN EUROPE 2021–2027 ($ BILLION)
EXHIBIT 103 INCREMENTAL GROWTH BY PRODUCT 2021 & 2027
EXHIBIT 104 INCREMENTAL GROWTH BY BIOLOGICS 2021 & 2027
EXHIBIT 105 INCREMENTAL GROWTH BY EXPRESSION SYSTEM 2021 & 2027
EXHIBIT 106 INCREMENTAL GROWTH BY SCALE OF OPERATION 2021 & 2027
EXHIBIT 107 INCREMENTAL GROWTH BY COMPANY SIZE 2021 & 2027
EXHIBIT 108 INCREMENTAL GROWTH IN EUROPE 2021 & 2027
EXHIBIT 109 BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET IN GERMANY 2021–2027 ($ BILLION)
EXHIBIT 110 BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET IN FRANCE 2021–2027 ($ BILLION)
EXHIBIT 111 BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET IN UK 2021–2027 ($ BILLION)
EXHIBIT 112 BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET IN SWITZERLAND 2021–2027 ($ BILLION)
EXHIBIT 113 BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET IN ITALY 2021–2027 ($ BILLION)
EXHIBIT 114 BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET IN SPAIN 2021–2027 ($ BILLION)
EXHIBIT 115 BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET IN APAC: KEY COUNTRIES
EXHIBIT 116 BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET IN APAC: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 117 BIOPHARMACEUTICAL CONTRACT MANUFACTURING IN APAC 2021–2027 ($ BILLION)
EXHIBIT 118 INCREMENTAL GROWTH BY PRODUCT 2021 & 2027
EXHIBIT 119 INCREMENTAL GROWTH BY BIOLOGICS 2021 & 2027
EXHIBIT 120 INCREMENTAL GROWTH BY EXPRESSION SYSTEM 2021 & 2027
EXHIBIT 121 INCREMENTAL GROWTH BY SCALE OF OPERATION 2021 & 2027
EXHIBIT 122 INCREMENTAL GROWTH BY COMPANY SIZE 2021 & 2027
EXHIBIT 123 INCREMENTAL GROWTH IN APAC 2021 & 2027
EXHIBIT 124 BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET IN CHINA 2021–2027 ($ BILLION)
EXHIBIT 125 BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET IN JAPAN 2021–2027 ($ BILLION)
EXHIBIT 126 CELL & GENE THERAPY CLINICAL TRIALS IN SOUTH KOREA 2021
EXHIBIT 127 BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET IN SOUTH KOREA 2021–2027 ($ BILLION)
EXHIBIT 128 BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET IN INDIA 2021–2027 ($ BILLION)
EXHIBIT 129 BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET IN AUSTRALIA 2021–2027 ($ BILLION)
EXHIBIT 130 BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET IN LATIN AMERICA: KEY COUNTRIES
EXHIBIT 131 BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET IN LATIN AMERICA: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 132 BIOPHARMACEUTICAL CONTRACT MANUFACTURING IN LATIN AMERICA 2021–2027 ($ BILLION)
EXHIBIT 133 INCREMENTAL GROWTH BY PRODUCT 2021 & 2027
EXHIBIT 134 INCREMENTAL GROWTH BY BIOLOGICS 2021 & 2027
EXHIBIT 135 INCREMENTAL GROWTH BY EXPRESSION SYSTEM 2021 & 2027
EXHIBIT 136 INCREMENTAL GROWTH BY SCALE OF OPERATION 2021 & 2027
EXHIBIT 137 INCREMENTAL GROWTH BY COMPANY SIZE 2021 & 2027
EXHIBIT 138 INCREMENTAL GROWTH IN LATIN AMERICA 2021 & 2027
EXHIBIT 139 BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET IN BRAZIL 2021–2027 ($ BILLION)
EXHIBIT 140 BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET IN MEXICO 2021–2027 ($ BILLION)
EXHIBIT 141 BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET IN ARGENTINA 2021–2027 ($ BILLION)
EXHIBIT 142 BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET IN MIDDLE EAST & AFRICA: KEY COUNTRIES
EXHIBIT 143 BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET IN MIDDLE EAST & AFRICA: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 144 BIOPHARMACEUTICAL CONTRACT MANUFACTURING IN MIDDLE EAST & AFRICA 2021–2027 ($ BILLION)
EXHIBIT 145 INCREMENTAL GROWTH BY PRODUCT 2021 & 2027
EXHIBIT 146 INCREMENTAL GROWTH BY BIOLOGICS 2021 & 2027
EXHIBIT 147 INCREMENTAL GROWTH BY EXPRESSION SYSTEM 2021 & 2027
EXHIBIT 148 INCREMENTAL GROWTH BY SCALE OF OPERATION 2021 & 2027
EXHIBIT 149 INCREMENTAL GROWTH BY COMPANY SIZE 2021 & 2027
EXHIBIT 150 INCREMENTAL GROWTH IN MIDDLE EAST & AFRICA 2021 & 2027
EXHIBIT 151 BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET IN TURKEY 2021–2027 ($ BILLION)
EXHIBIT 152 BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET IN SAUDI ARABIA 2021–2027 ($ BILLION)
EXHIBIT 153 BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET IN UAE 2021–2027 ($ BILLION)
EXHIBIT 154 BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET IN SOUTH AFRICA 2021–2027 ($ BILLION)
EXHIBIT 155 GLOBAL BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET: KEY VENDORS STRENGTHS & CAPABILITIES ASSESSMENT
EXHIBIT 156 GLOBAL BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET: VENDOR RANKING 2022 (BY MANUFACTURING CAPACITY VOLUME)
EXHIBIT 157 BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET CAPABILITIES & EXPERTISE ASSESSMENT
EXHIBIT 158 BOEHRINGER INGELHEIM: TOTAL SALES 2019-2021 ($ BILLION)
EXHIBIT 159 BOEHRINGER INGELHEIM: REVENUE BY BUSINESS UNIT (%)
EXHIBIT 160 BOEHRINGER INGELHEIM: REVENUE BY REGION (%)
EXHIBIT 161 LONZA: TOTAL SALES 2019-2021 ($ MILLION)
EXHIBIT 162 LONZA: REVENUE BY REPORTABLE DIVISIONS (%)
EXHIBIT 163 LONZA: REVENUE BY REGION (%)
EXHIBIT 164 SAMSUNG BIOLOGICS: TOTAL SALES 2019-2021 ($ MILLION)
EXHIBIT 165 SAMSUNG BIOLOGICS: REVENUE SHARE BY PRODUCT TYPE 2021 (%)
EXHIBIT 166 SAMSUNG BIOLOGICS: REVENUE SHARE BY GEOGRAPHY 2021 (%)
EXHIBIT 167 ABBVIE: TOTAL SALES 2019-2021 ($ BILLION)
EXHIBIT 168 ABBVIE: REVENUE BY RESEARCH & DEVELOPMENT EXPENDITURE ($ BILLION)
EXHIBIT 169 ABBVIE: REVENUE BY REGION ($ BILLION)
EXHIBIT 170 CATALENT: TOTAL SALES 2019-2021 ($ MILLION)
EXHIBIT 171 CATALENT: REVENUE BY BUSINESS SEGMENT 2021 (%)
EXHIBIT 172 FUJIFILM: TOTAL SALES 2018-2020 ($ BILLION)
EXHIBIT 173 FUJIFILM: REVENUE BY BUSINESS SEGMENT (%)
EXHIBIT 174 MERCK KGAA: TOTAL SALES 2019-2021 ($ BILLION)
EXHIBIT 175 MERCK KGAA: REVENUE SHARE BY BUSINESS SEGMENT (%)
EXHIBIT 176 MERCK KGAA: REVENUE SHARE BY REGION (%)
EXHIBIT 177 PFIZER: TOTAL SALES 2019-2021 ($ BILLION)
EXHIBIT 178 PFIZER: RESEARCH & DEVELOPMENT EXPENDITURE ($ BILLION)
EXHIBIT 179 PFIZER: REVENUE SHARE BY OPERATING SEGMENT ($ BILLION)
EXHIBIT 180 WUXI BIOLOGICS: TOTAL SALES 2019-2021 ($ BILLION)
EXHIBIT 181 WUXI BIOLOGICS: REVENUE BY REGION ($ BILLION)
LIST OF TABLES
TABLE 1 KEY CAVEATS
TABLE 2 CURRENCY CONVERSION 2015−2021
TABLE 3 MAJOR INVESTMENTS BY CMOS IN GENE THERAPY DEVELOPMENT
TABLE 4 LIST OF RECENT MERGER & ACQUISITIONS AMONG BIOPHARMACEUTICAL CONTRACT MANUFACTURERS
TABLE 5 BIOPHARMACEUTICAL PIPELINE DRUGS
TABLE 6 MAJOR INVESTMENTS BY CMOS IN GENE THERAPY DEVELOPMENT
TABLE 7 BIOPHARMACEUTICAL PIPELINE DRUGS
TABLE 8 DNA TO FILL-FINISH SERVICE OFFERING MAJOR CDMOS
TABLE 9 COST OF KYMRIAH IN DIFFERENT REGIONS
TABLE 10 VACCINE CANDIDATES IN DEVELOPMENT
TABLE 11 COMMERCIAL VACCINE CANDIDATES IN THE WORLD
TABLE 12 BIOPHARMACEUTICALS IN CLINICAL TRIALS BY PRODUCT CATEGORIES
TABLE 13 BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET IN NORTH AMERICA BY PRODUCT 2021−2027 ($ BILLION)
TABLE 14 BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET IN NORTH AMERICA BY PRODUCT 2021−2027 (%)
TABLE 15 BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET IN NORTH AMERICA BY BIOLOGICS 2021−2027 ($ BILLION)
TABLE 16 BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET IN NORTH AMERICA BY BIOLOGICS 2021−2027 (%)
TABLE 17 BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET IN NORTH AMERICA BY EXPRESSION SYSTEM 2021−2027 ($ BILLION)
TABLE 18 BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET IN NORTH AMERICA BY EXPRESSION SYSTEM 2021−2027 (%)
TABLE 19 BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET IN NORTH AMERICA BY SCALE OF OPERATION 2021−2027 ($ BILLION)
TABLE 20 BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET IN NORTH AMERICA BY SCALE OF OPERATION 2021−2027 (%)
TABLE 21 BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET IN NORTH AMERICA BY COMPANY SIZE 2021−2027 ($ BILLION)
TABLE 22 BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET IN NORTH AMERICA BY COMPANY SIZE 2021−2027 (%)
TABLE 23 BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET IN EUROPE BY PRODUCT 2021−2027 ($ BILLION)
TABLE 24 BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET IN EUROPE BY PRODUCT 2021−2027 (%)
TABLE 25 BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET IN EUROPE BY BIOLOGICS 2021−2027 ($ BILLION)
TABLE 26 BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET IN EUROPE BY BIOLOGICS 2021−2027 (%)
TABLE 27 BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET IN EUROPE BY EXPRESSION SYSTEM 2021−2027 ($ BILLION)
TABLE 28 BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET IN EUROPE BY EXPRESSION SYSTEM 2021−2027 (%)
TABLE 29 BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET IN EUROPE BY SCALE OF OPERATION 2021−2027 ($ BILLION)
TABLE 30 BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET IN EUROPE BY SCALE OF OPERATION 2021−2027 (%)
TABLE 31 BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET IN EUROPE BY COMPANY SIZE 2021−2027 ($ BILLION)
TABLE 32 BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET IN EUROPE BY COMPANY SIZE 2021−2027 (%)
TABLE 33 BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET IN APAC BY PRODUCT 2021−2027 ($ BILLION)
TABLE 34 BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET IN APAC BY PRODUCT 2021−2027 (%)
TABLE 35 BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET IN APAC BY BIOLOGICS 2021−2027 ($ BILLION)
TABLE 36 BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET IN APAC BY BIOLOGICS 2021−2027 (%)
TABLE 37 BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET IN APAC BY EXPRESSION SYSTEM 2021−2027 ($ BILLION)
TABLE 38 BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET IN APAC BY EXPRESSION SYSTEM 2021−2027 (%)
TABLE 39 BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET IN APAC BY SCALE OF OPERATION 2021−2027 ($ BILLION)
TABLE 40 BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET IN APAC BY SCALE OF OPERATION 2021−2027 (%)
TABLE 41 BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET IN APAC BY COMPANY SIZE 2021−2027 ($ BILLION)
TABLE 42 BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET IN APAC BY COMPANY SIZE 2021−2027 (%)
TABLE 43 BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET IN LATIN AMERICA BY PRODUCT 2021−2027 ($ BILLION)
TABLE 44 BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET IN LATIN AMERICA BY PRODUCT 2021−2027 (%)
TABLE 45 BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET IN LATIN AMERICA BY BIOLOGICS 2021−2027 ($ BILLION)
TABLE 46 BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET IN LATIN AMERICA BY BIOLOGICS 2021−2027 (%)
TABLE 47 BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET IN LATIN AMERICA BY EXPRESSION SYSTEM 2021−2027 ($ BILLION)
TABLE 48 BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET IN LATIN AMERICA BY EXPRESSION SYSTEM 2021−2027 (%)
TABLE 49 BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET IN LATIN AMERICA BY SCALE OF OPERATION 2021−2027 ($ BILLION)
TABLE 50 BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET IN LATIN AMERICA BY SCALE OF OPERATION 2021−2027 (%)
TABLE 51 BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET IN LATIN AMERICA BY COMPANY SIZE 2021−2027 ($ BILLION)
TABLE 52 BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET IN LATIN AMERICA BY COMPANY SIZE 2021−2027 (%)
TABLE 53 BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET IN MIDDLE EAST & AFRICA BY PRODUCT 2021−2027 ($ BILLION)
TABLE 54 BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET IN MIDDLE EAST & AFRICA BY PRODUCT 2021−2027 (%)
TABLE 55 BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET IN MIDDLE EAST & AFRICA BY BIOLOGICS 2021−2027 ($ BILLION)
TABLE 56 BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET IN MIDDLE EAST & AFRICA BY BIOLOGICS 2021−2027 (%)
TABLE 57 BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET IN MIDDLE EAST & AFRICA BY EXPRESSION SYSTEM 2021−2027 ($ BILLION)
TABLE 58 BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET IN MIDDLE EAST & AFRICA BY EXPRESSION SYSTEM 2021−2027 (%)
TABLE 59 BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET IN MIDDLE EAST & AFRICA BY SCALE OF OPERATION 2021−2027 ($ BILLION)
TABLE 60 BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET IN MIDDLE EAST & AFRICA BY SCALE OF OPERATION 2021−2027 (%)
TABLE 61 BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET IN MIDDLE EAST & AFRICA BY COMPANY SIZE 2021−2027 ($ BILLION)
TABLE 62 BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET IN MIDDLE EAST & AFRICA BY COMPANY SIZE 2021−2027 (%)
TABLE 63 BOEHRINGER INGELHEIM: MAJOR SERVICE OFFERINGS
TABLE 64 LONZA: MAJOR SERVICE OFFERINGS
TABLE 65 SAMSUNG BIOLOGICS: MAJOR SERVICE OFFERINGS
TABLE 66 ABBVIE: MAJOR SERVICE OFFERINGS
TABLE 67 CATALENT: MAJOR SERVICE OFFERINGS
TABLE 68 EMERGENT BIOSOLUTIONS: MAJOR SERVICE OFFERINGS
TABLE 69 FUJIFILM: MAJOR SERVICE OFFERINGS
TABLE 70 MERCK KGAA: MAJOR SERVICE OFFERINGS
TABLE 71 PFIZER: MAJOR SERVICE OFFERINGS
TABLE 72 SERUM INSTITUTE OF INDIA: MAJOR SERVICE OFFERINGS
TABLE 73 WUXI BIOLOGICS: MAJOR SERVICE OFFERINGS
TABLE 74 AGC BIOLOGICS: MAJOR SERVICE OFFERINGS
TABLE 75 AJINOMOTO: MAJOR SERVICE OFFERINGS
TABLE 76 ALBANY MOLECULAR RESEARCH: MAJOR SERVICE OFFERINGS
TABLE 77 ASYMCHEM: MAJOR SERVICE OFFERINGS
TABLE 78 BIOCINA: MAJOR SERVICE OFFERINGS
TABLE 79 BIOCON: MAJOR SERVICE OFFERINGS
TABLE 80 COBRA BIOLOGICS: MAJOR SERVICE OFFERINGS
TABLE 81 CHARLES RIVER LABORATORIES: MAJOR SERVICE OFFERINGS
TABLE 82 GOODWIN BIOTECHNOLOGY: MAJOR SERVICE OFFERINGS
TABLE 83 KBI BIOPHARMA: MAJOR SERVICE OFFERINGS
TABLE 84 SANOFI: MAJOR SERVICE OFFERINGS
TABLE 85 BAVARIAN NORDIC: MAJOR SERVICE OFFERINGS
TABLE 86 WACKER BIOTECH B.V: MAJOR SERVICE OFFERINGS
TABLE 87 JUBILANT HOLLISTERSTIER: MAJOR SERVICE OFFERINGS
TABLE 88 NATIONAL RESILIENCE: MAJOR SERVICE OFFERINGS
TABLE 89 NOVASEP: MAJOR SERVICE OFFERINGS
TABLE 90 KEMWELL BIOPHARMA: MAJOR SERVICE OFFERINGS
TABLE 91 MIDAS PHARMA: MAJOR SERVICE OFFERINGS
TABLE 92 ALCAMI: MAJOR SERVICE OFFERINGS
TABLE 93 CAMBREX: MAJOR SERVICE OFFERINGS
TABLE 94 PHARMACEUTICS INTERNATIONAL: MAJOR SERVICE OFFERINGS
TABLE 95 SINGOTA SOLUTIONS: MAJOR SERVICE OFFERINGS
TABLE 96 THERMO FISHER SCIENTIFIC: MAJOR SERVICE OFFERINGS
TABLE 97 BINEX: MAJOR SERVICE OFFERINGS
TABLE 98 CANTON BIOLOGICS: MAJOR SERVICE OFFERINGS
TABLE 99 CHEMPARTNER: MAJOR SERVICE OFFERINGS
TABLE 100 CYTOVANCE BIOLOGICS: MAJOR SERVICE OFFERINGS
TABLE 101 GLOBAL BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY PRODUCT 2021−2027 ($ BILLION)
TABLE 102 GLOBAL BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY PRODUCT 2021−2027 (%)
TABLE 103 NORTH AMERICA BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY PRODUCT 2021−2027 ($ BILLION)
TABLE 104 NORTH AMERICA BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY PRODUCT 2021−2027 (%)
TABLE 105 EUROPE BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY PRODUCT 2021−2027 ($ BILLION)
TABLE 106 EUROPE BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY PRODUCT 2021−2027 (%)
TABLE 107 APAC BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY PRODUCT 2021−2027 ($ BILLION)
TABLE 108 APAC BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY PRODUCT 2021−2027 (%)
TABLE 109 LATIN AMERICA BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY PRODUCT 2021−2027 ($ BILLION)
TABLE 110 LATIN AMERICA BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY PRODUCT 2021−2027 (%)
TABLE 111 MIDDLE EAST & AFRICA BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY PRODUCT 2021−2027 ($ BILLION)
TABLE 112 MIDDLE EAST & AFRICA BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY PRODUCT 2021−2027 (%)
TABLE 113 GLOBAL BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY BIOLOGICS 2021−2027 ($ BILLION)
TABLE 114 GLOBAL BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY BIOLOGICS 2021−2027 (%)
TABLE 115 NORTH AMERICA BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY BIOLOGICS 2021−2027 ($ BILLION)
TABLE 116 NORTH AMERICA BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY BIOLOGICS 2021−2027 (%)
TABLE 117 EUROPE BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY BIOLOGICS 2021−2027 ($ BILLION)
TABLE 118 EUROPE BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY BIOLOGICS 2021−2027 (%)
TABLE 119 APAC BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY BIOLOGICS 2021−2027 ($ BILLION)
TABLE 120 APAC BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY BIOLOGICS 2021−2027 (%)
TABLE 121 LATIN AMERICA BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY BIOLOGICS 2021−2027 ($ BILLION)
TABLE 122 LATIN AMERICA BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY BIOLOGICS 2021−2027 (%)
TABLE 123 MIDDLE EAST & AFRICA BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY BIOLOGICS 2021−2027 ($ BILLION)
TABLE 124 MIDDLE EAST & AFRICA BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY BIOLOGICS 2021−2027 (%)
TABLE 125 GLOBAL BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY EXPRESSION SYSTEM 2021−2027 ($ BILLION)
TABLE 126 GLOBAL BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY EXPRESSION SYSTEM2021−2027 (%)
TABLE 127 NORTH AMERICA BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY EXPRESSION SYSTEM 2021−2027 ($ BILLION)
TABLE 128 NORTH AMERICA BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY EXPRESSION SYSTEM 2021−2027 (%)
TABLE 129 EUROPE BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY EXPRESSION SYSTEM 2021−2027 ($ BILLION)
TABLE 130 EUROPE BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY EXPRESSION SYSTEM 2021−2027 (%)
TABLE 131 APAC BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY EXPRESSION SYSTEM 2021−2027 ($ BILLION)
TABLE 132 APAC BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY EXPRESSION SYSTEM 2021−2027 (%)
TABLE 133 LATIN AMERICA BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY EXPRESSION SYSTEM 2021−2027 ($ BILLION)
TABLE 134 LATIN AMERICA BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY EXPRESSION SYSTEM 2021−2027 (%)
TABLE 135 MIDDLE EAST & AFRICA BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY EXPRESSION SYSTEM 2021−2027 ($ BILLION)
TABLE 136 MIDDLE EAST & AFRICA BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY EXPRESSION SYSTEM 2021−2027 (%)
TABLE 137 GLOBAL BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY SCALE OF OPERATION 2021−2027 ($ BILLION)
TABLE 138 GLOBAL BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY SCALE OF OPERATION 2021−2027 (%)
TABLE 139 NORTH AMERICA BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY SCALE OF OPERATION 2021−2027 ($ BILLION)
TABLE 140 NORTH AMERICA BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY SCALE OF OPERATION 2021−2027 (%)
TABLE 141 EUROPE BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY SCALE OF OPERATION 2021−2027 ($ BILLION)
TABLE 142 EUROPE BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY SCALE OF OPERATION 2021−2027 (%)
TABLE 143 APAC BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY SCALE OF OPERATION 2021−2027 ($ BILLION)
TABLE 144 APAC BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY SCALE OF OPERATION 2021−2027 (%)
TABLE 145 LATIN AMERICA BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY SCALE OF OPERATION 2021−2027 ($ BILLION)
TABLE 146 LATIN AMERICA BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY SCALE OF OPERATION 2021−2027 (%)
TABLE 147 MIDDLE EAST & AFRICA BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY SCALE OF OPERATION 2021−2027 ($ BILLION)
TABLE 148 MIDDLE EAST & AFRICA BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY SCALE OF OPERATION 2021−2027 (%)
TABLE 149 GLOBAL BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY COMPANY SIZE 2021−2027 ($ BILLION)
TABLE 150 GLOBAL BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY COMPANY SIZE 2021−2027 (%)
TABLE 151 NORTH AMERICA BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY COMPANY SIZE 2021−2027 ($ BILLION)
TABLE 152 NORTH AMERICA BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY COMPANY SIZE 2021−2027 (%)
TABLE 153 EUROPE BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY COMPANY SIZE 2021−2027 ($ BILLION)
TABLE 154 EUROPE BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY COMPANY SIZE 2021−2027 (%)
TABLE 155 APAC BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY COMPANY SIZE 2021−2027 ($ BILLION)
TABLE 156 APAC BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY COMPANY SIZE 2021−2027 (%)
TABLE 157 LATIN AMERICA BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY COMPANY SIZE 2021−2027 ($ BILLION)
TABLE 158 LATIN AMERICA BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY COMPANY SIZE 2021−2027 (%)
TABLE 159 MIDDLE EAST & AFRICA BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY COMPANY SIZE 2021−2027 ($ BILLION)
TABLE 160 MIDDLE EAST & AFRICA BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY COMPANY SIZE 2021−2027 (%)
TABLE 161 GLOBAL BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY GEOGRAPHY 2021−2027 ($ BILLION)
TABLE 162 GLOBAL BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY GEOGRAPHY 2021−2027 (%)
TABLE 163 GLOBAL BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY ACTIVE PHARMACEUTICAL INGREDIENTS (APIS) 2021−2027 ($ BILLION)
TABLE 164 GLOBAL BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY ACTIVE PHARMACEUTICAL INGREDIENTS (APIS) 2021−2027 (%)
TABLE 165 GLOBAL BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY FINISHED DOSAGE FORM (FDF) 2021−2027 ($ BILLION)
TABLE 166 GLOBAL BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY FINISHED DOSAGE FORM (FDF) 2021−2027 (%)
TABLE 167 GLOBAL BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY MONOCLONAL ANTIBODIES (MABS) 2021−2027 ($ BILLION)
TABLE 168 GLOBAL BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY MONOCLONAL ANTIBODIES (MABS) 2021−2027 (%)
TABLE 169 GLOBAL BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY VACCINES 2021−2027 ($ BILLION)
TABLE 170 GLOBAL BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY VACCINES 2021−2027 (%)
TABLE 171 GLOBAL BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY OTHERS 2021−2027 ($ BILLION)
TABLE 172 GLOBAL BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY OTHERS 2021−2027 (%)
TABLE 173 GLOBAL BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY MAMMALIAN 2021−2027 ($ BILLION)
TABLE 174 GLOBAL BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY MAMMALIAN 2021−2027 (%)
TABLE 175 GLOBAL BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY NON-MAMMALIAN 2021−2027 ($ BILLION)
TABLE 176 GLOBAL BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY NON-MAMMALIAN 2021−2027 (%)
TABLE 177 GLOBAL BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY COMMERCIAL 2021−2027 ($ BILLION)
TABLE 178 GLOBAL BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY COMMERCIAL 2021−2027 (%)
TABLE 179 GLOBAL BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY RESEARCH (CLINICAL & PRECLINICAL) 2021−2027 ($ BILLION)
TABLE 180 GLOBAL BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY RESEARCH (CLINICAL & PRECLINICAL) 2021−2027 (%)
TABLE 181 GLOBAL BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY LARGE COMPANIES 2021−2027 ($ BILLION)
TABLE 182 GLOBAL BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY LARGE COMPANIES 2021−2027 (%)
TABLE 183 GLOBAL BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY SMALL & MID-SIZED COMPANIES 2021−2027 ($ BILLION)
TABLE 184 GLOBAL BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY SMALL & MID-SIZED COMPANIES 2021−2027 (%)